noom glp 1 reviews side effects jumps into off-brand weight loss drug market Noom GLP-1 Review 2026: Great

Related Stories Endotrophin may reveal metabolic risks linked to changing body fat Medically tailored grocery deliveries improve blood sugar control among diabetes patients Diet helps people lose weight regardless of genetic obesity risk Tirzepatide is being studied in the Study of Tirzepatide in Pediatric Participants with Type 2 Diabetes (SURPASS-PEDS) trial for children and adolescents with type 2 diabetes and the SURPASS-2 trial for those with obesity or overweight and related comorbidities

They are not indicated for type 1 diabetes, should not be used with DPP-4 inhibitors, and require caution in patients with pancreatitis history or diabetic retinopathy

AKI is characterized by an increase in serum creatinine, oliguria, and the presence of kidney damage markers such as albuminuria, electrolyte abnormalities due to tubular disorders, or structural damage seen in imaging or histology [9]

[DOI] [PubMed] [Google Scholar] 202.Kawano Y, Cohen DE